Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database.
Sakurai A, Suzuki S, Kosugi S, Okamoto T, Uchino S, Miya A, Imai T, Kaji H, Komoto I, Miura D, Yamada M, Uruno T, Horiuchi K, Miyauchi A, Imamura M; MEN Consortium of Japan; Fukushima T, Hanazaki K, Hirakawa S, Igarashi T, Iwatani T, Kammori M, Katabami T, Katai M, Kikumori T, Kiribayashi K, Koizumi S, Midorikawa S, Miyabe R, Munekage T, Ozawa A, Shimizu K, Sugitani I, Takeyama H, Yamazaki M. Sakurai A, et al. Among authors: iwatani t. Clin Endocrinol (Oxf). 2012 Apr;76(4):533-9. doi: 10.1111/j.1365-2265.2011.04227.x. Clin Endocrinol (Oxf). 2012. PMID: 21950691
Putative tumor suppressor EDD interacts with and up-regulates APC.
Ohshima R, Ohta T, Wu W, Koike A, Iwatani T, Henderson M, Watts CK, Otsubo T. Ohshima R, et al. Among authors: iwatani t. Genes Cells. 2007 Dec;12(12):1339-45. doi: 10.1111/j.1365-2443.2007.01138.x. Genes Cells. 2007. PMID: 18076571 Free article.
Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastatic breast cancer: study protocol for a randomized controlled, non-inferiority, phase III trial in Japan (JBCRG-M06/EMERALD).
Yamashita T, Masuda N, Saji S, Araki K, Ito Y, Takano T, Takahashi M, Tsurutani J, Koizumi K, Kitada M, Kojima Y, Sagara Y, Tada H, Iwasa T, Kadoya T, Iwatani T, Hasegawa H, Morita S, Ohno S. Yamashita T, et al. Among authors: iwatani t. Trials. 2020 May 7;21(1):391. doi: 10.1186/s13063-020-04341-y. Trials. 2020. PMID: 32381018 Free PMC article. Clinical Trial.
Correction to: Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastatic breast cancer: study protocol for a randomized controlled, non-inferiority, phase III trial in Japan (JBCRG-M06/EMERALD).
Yamashita T, Masuda N, Saji S, Araki K, Ito Y, Takano T, Takahashi M, Tsurutani J, Koizumi K, Kitada M, Kojima Y, Sagara Y, Tada H, Iwasa T, Kadoya T, Iwatani T, Hasegawa H, Morita S, Ohno S. Yamashita T, et al. Among authors: iwatani t. Trials. 2020 Jun 8;21(1):503. doi: 10.1186/s13063-020-04408-w. Trials. 2020. PMID: 32513251 Free PMC article.
Current Status of Advance Care Planning and End-of-life Communication for Patients with Advanced and Metastatic Breast Cancer.
Sagara Y, Mori M, Yamamoto S, Eguchi K, Iwatani T, Naito Y, Kogawa T, Tanaka K, Kotani H, Yasojima H, Ozaki Y, Noguchi E, Miyasita M, Kondo N, Niikura N, Toi M, Shien T, Iwata H. Sagara Y, et al. Among authors: iwatani t. Oncologist. 2021 Apr;26(4):e686-e693. doi: 10.1002/onco.13640. Epub 2021 Jan 2. Oncologist. 2021. PMID: 33321004 Free PMC article.
Patient-reported outcome and quality of life research policy: Japan Clinical Oncology Group (JCOG) policy.
Ishiki H, Kikawa Y, Terada M, Mizusawa J, Honda M, Iwatani T, Mizutani T, Mori K, Nakamura N, Miyaji T, Yamaguchi T, Ando M, Nakamura K, Fukuda H, Kiyota N; PRO/QOL research Committee of Japan Clinical Oncology Group. Ishiki H, et al. Among authors: iwatani t. Jpn J Clin Oncol. 2023 Mar 7;53(3):195-202. doi: 10.1093/jjco/hyad007. Jpn J Clin Oncol. 2023. PMID: 36702740 Free PMC article.
49 results